Heron Therapeutics, Inc. (NASDAQ:HRTX)

CAPS Rating: No stars

A specialty pharmaceutical company focused on developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.

Recs

0
Player Avatar pchop123 (79.69) Submitted: 11/27/2012 7:03:03 PM : Underperform Start Price: $10.40 HRTX Score: +5.96

too much dilution for me

Featured Broker Partners


Advertisement